Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03851744 · ClinicalTrials.gov registry record · NA
High Altitude and Exogenous Carbohydrate Oxidation
A NA study, sponsored by United States Army Research Institute of Environmental Medicine.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03851744 is a NA study that has completed, run by United States Army Research Institute of Environmental Medicine. The registered enrollment target is 10 participants.
The verdict
NCT03851744, a NA study, has completed, sponsored by United States Army Research Institute of Environmental Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Recent studies have reported that oxidation of exogenous carbohydrate is reduced under acute hypobaric hypoxic (high altitude; HA) conditions compared to normoxia (sea level; SL) in native lowlanders. However, the mechanisms by which HA suppresses exogenous carbohydrate oxidation are not known. This study will seek to confirm that acute HA exposure decreases exogenous carbohydrate oxidation during steady-state aerobic exercise compared to SL, and explore if the mechanism inhibiting plasma glucose uptake is insulin dependent or independent.
Interventions
- OTHER Sea Level
- OTHER High Altitude
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-11-28 |
| Est. Completion | 2020-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03851744
The ClinicalTrials.gov registry entry for NCT03851744 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is United States Army Research Institute of Environmental Medicine, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sea Level is the first listed.
NCT03851744 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03851744 about?
NCT03851744 is a clinical study titled "High Altitude and Exogenous Carbohydrate Oxidation". Recent studies have reported that oxidation of exogenous carbohydrate is reduced under acute hypobaric hypoxic (high altitude; HA) conditions compared to normoxia (sea level; SL) in native lowlanders. However, the mechanisms by which HA suppresses exogenous carbohydrate oxidation are not known. This...
What is the current status of trial NCT03851744?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2018-11-28. Estimated completion is 2020-09-01.
What interventions are being tested in trial NCT03851744?
The interventions under investigation include: Sea Level (OTHER), High Altitude (OTHER).
Who is sponsoring clinical trial NCT03851744?
This trial is sponsored by United States Army Research Institute of Environmental Medicine, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.